When compared with all control groups (including placebo, basal insulin, and GLP1-RA), our analysis did not show a statistically significant association between tirzepatide use and the incidence of cholelithiasis, cholecystitis, biliary diseases, or the the composite of gallbladder or biliary diseases, as shown in Supplementary Figure S6
Oral options might increase their willingness to initiate and adhere to treatment, potentially broadening the pool of people who can benefit from [GLP-1] therapy. Maintenance therapy after weight loss For people whove already lost weight with an injectable GLP-1, switching to a pill may help maintain progress without continuing injections
This type of loss follows specific patterns: receding hairline and crown thinning in men, widening part and diffuse thinning in women
When you are prepared to use your semaglutide pen, securely insert the pen cap into your chosen injection site
While effective for diabetes and obesity, semaglutide may cause joint pain through inflammation, blood sugar changes, weight loss, and cartilage effects
Week 13-16 1.7 mg once weekly The dose is further increased